Vertex Planning Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,526
Closed -$1.02M 171
2025
Q3
$1.02M Buy
5,526
+224
+4% +$38.4K 0.2% 70
2025
Q2
$810K Sell
5,302
-31
-0.6% -$4.76K 0.17% 75
2025
Q1
$884K Sell
5,333
-57
-1% -$8.92K 0.19% 65
2024
Q4
$780K Buy
5,390
+179
+3% +$27.7K 0.17% 74
2024
Q3
$844K Buy
5,211
+65
+1% +$10.4K 0.2% 56
2024
Q2
$752K Sell
5,146
-62
-1% -$9.22K 0.2% 60
2024
Q1
$824K Sell
5,208
-311
-6% -$49.5K 0.23% 53
2023
Q4
$865K Buy
5,519
+9
+0.2% +$1.38K 0.26% 49
2023
Q3
$858K Sell
5,510
-211
-4% -$34.8K 0.3% 43
2023
Q2
$947K Buy
5,721
+3,178
+125% +$513K 0.32% 45
2023
Q1
$394K Sell
2,543
-1,851
-42% -$299K 0.15% 72
2022
Q4
$776K Buy
+4,394
New +$759K 0.3% 44

Other funds holding JNJ

Vertex Planning Partners's JNJ Position: Q4 2025 in Review

Vertex Planning Partners sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 5,526 shares — an estimated $1.02M sold.

Vertex Planning Partners first reported a position in JNJ in Q4 2022 and held it in 12 quarters. The position peaked at $1.02M in Q3 2025. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Vertex Planning Partners reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Vertex Planning Partners sold 5,526 Johnson & Johnson shares in Q4 2025, an estimated $1.02M.
  • Vertex Planning Partners first reported a position in Johnson & Johnson in Q4 2022 and held it in 12 quarters.
  • Vertex Planning Partners's Johnson & Johnson position peaked at $1.02M in Q3 2025.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Vertex Planning Partners's 13F filing for Q4 2025, filed 17 Feb 2026.